NYRx, The Medicaid Pharmacy Program Notice to Providers: Program Update

The NYRx Clinical Call Center is experiencing higher than normal call and fax volume. Prescribers should not send duplicate prior authorization (PA) requests to NYRx. Prescribers may experience a higher volume of requests for PA, but only one submission is necessary. Pharmacies should only request one PA for each member for each drug. Duplicate requests slow down the processing time at the NYRx Clinical Call Center. For more information, refer to NYRx Notice to Providers: Duplicate Prior Authorization Requests. To review how to submit a PA to NYRx, refer to the NYRx Prior Authorization Submission Guide.

Enhancements have been made to the NYRx clinical criteria system editing. The clinical criteria have not changed and should be reviewed on the NYRx Preferred Drug List prior to obtaining a PA. Preferred products should be prescribed when clinically appropriate. In most cases, preferred products will not require a PA when prescribed according to FDA labeling. To review NYRx preferred products only, refer to the NYRx Preferred Drug Quick List.

Resources

For more information regarding specific NYRx drug class criteria, refer to the following drug class coverage overviews:

Additional drug class coverage overviews are available on the NYRx Education & Outreach website.

Contact Information

The NYRx E&O Call Center is available by phone at 1-833-967-7310 from 8:00 AM to 5:00 PM ET, Monday through Friday, excluding holidays, or by email at [email protected].

The NYRx E&O team hosts virtual office hours every week for stakeholders to ask questions related to NYRx and care coordination. Office hours are also available by appointment. For more information, email [email protected] or visit the NYRx Education & Outreach website.

Categories: PulsePublished On: March 7th, 2024Tags: , ,

Share

Related Posts

  • Change Healthcare by Changing Change Healthcare Colleagues: New York City-based NYC Health + Hospitals has made the switch from Change Healthcare to Experian because of the cyberattack on the claims processing vendor. Change turned many of its IT systems offline following the Feb. 21 hack, and that left many hospitals and physician practices unable to […]

  • Federal Investigation into Private Equity, Consolidation in Medicine Three federal agencies are investigating the impact of private equity ownership and the broader consolidation of healthcare organizations on patient care and costs, prompting a wave of concern among physicians. According to Rhonda Wright, MD, from Brookhaven, Georgia, the influence of private equity has led to deteriorating […]

  • MSSNY’s Peer to Peer (P2P) Program Available to Help Stress and burnout among physicians have been documented for years, and can be overwhelming at times.  MSSNY’s peer supporters can help you gain a new perspective on your job and other life stressors.  MSSNY’s Peer to Peer (P2P) program affords physicians, residents, and medical students the […]

  • Baby Born Deaf Can Hear After Breakthrough Gene Therapy In a landmark advancement in gene therapy, Opal Sandy from Oxfordshire has shown remarkable progress in the global CHORD (Children Hearing and Oral Restoration through DNA) trial, significantly advancing the treatment of auditory neuropathy. This condition disrupts nerve impulses from the inner ear to the brain, […]